Optimal Aspergillus fumigatus and Asp f 1 serum IgG cut-offs for the diagnosis of allergic bronchopulmonary aspergillosis

  • Hamada Yuto
    Clinical Research Center for Allergy and Rheumatology, National Hospital Organization Sagamihara National Hospital Course of Allergy and Clinical Immunology, Juntendo University Graduate School of Medicine
  • Fukutomi Yuma
    Clinical Research Center for Allergy and Rheumatology, National Hospital Organization Sagamihara National Hospital Course of Allergy and Clinical Immunology, Juntendo University Graduate School of Medicine
  • Nakatani Eiji
    Division of Statistical Analysis, Research Support Center, Shizuoka General Hospital
  • Saito Akemi
    Clinical Research Center for Allergy and Rheumatology, National Hospital Organization Sagamihara National Hospital
  • Watai Kentaro
    Clinical Research Center for Allergy and Rheumatology, National Hospital Organization Sagamihara National Hospital
  • Kamide Yosuke
    Clinical Research Center for Allergy and Rheumatology, National Hospital Organization Sagamihara National Hospital
  • Sekiya Kiyoshi
    Clinical Research Center for Allergy and Rheumatology, National Hospital Organization Sagamihara National Hospital
  • Nagai Tadashi
    Central Blood Institute, Japanese Red Cross Society
  • Harada Kazuki
    Division of Pulmonary Medicine, Department of Medicine, Tokai University School of Medicine
  • Shiraishi Yoshiki
    Division of Pulmonary Medicine, Department of Medicine, Tokai University School of Medicine
  • Oguma Tsuyoshi
    Division of Pulmonary Medicine, Department of Medicine, Tokai University School of Medicine
  • Asano Koichiro
    Division of Pulmonary Medicine, Department of Medicine, Tokai University School of Medicine
  • Taniguchi Masami
    Clinical Research Center for Allergy and Rheumatology, National Hospital Organization Sagamihara National Hospital Course of Allergy and Clinical Immunology, Juntendo University Graduate School of Medicine Center for Immunology and Allergology, Shonan Kamakura General Hospital

Search this article

Abstract

<p>Background: The presence of IgG antibodies (Abs) to Aspergillus fumigatus (Af) is a crucial diagnostic criterion for allergic bronchopulmonary aspergillosis (ABPA). Although precipitation is traditionally used to document IgG Abs, anti-Af serum IgG levels can also be measured by enzyme immunoassay (EIA). However, there are insufficient data on the optimal cut-offs to assess diagnostic performance of the EIA method. This study aimed to determine cut-off levels of IgG binding crude Af extracts or recombinant Asp f 1 (by ImmunoCAP®) and to compare their efficacy for ABPA diagnosis with Af-precipitating Abs.</p><p>Methods: The age distribution of levels of IgG to crude extracts of Af (Af-IgG) and recombinant Asp f 1 (Asp f 1-IgG) was established using sera from 694 healthy controls (HC). Receiver operating characteristic analysis for Af-IgG and Asp f 1-IgG levels for the purpose of ABPA diagnosis was performed in 306 Af-sensitized asthma patients (including 49 ABPA), and cut-offs were determined.</p><p>Results: An age-dependent decline in the levels of Af-IgG was observed in HC. Thus, cut-offs for Af-IgG levels were determined separately by age as 60 mg/L for patients aged <55 years, and 45 mg/L for those aged ≥55 years. For Asp f 1-IgG, 6.6 mg/L was set as the cut-off regardless of age. Although such IgG testing by EIA allowed a sufficiently good diagnostic performance, Af-precipitating Abs had better diagnostic applicability for ABPA.</p><p>Conclusions: We determined cut-offs for Af-IgG and Asp f 1-IgG measured by EIA, which can be useful in clinical settings where precipitating Abs are unavailable.</p>

Journal

Citations (1)*help

See more

References(26)*help

See more

Related Projects

See more

Details 詳細情報について

Report a problem

Back to top